Last Updated: May 1, 2026

Profile for Hungary Patent: E072720


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E072720

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,596,276 Jan 25, 2039 Aaa Usa Inc LUTATHERA lutetium lu 177 dotatate
10,596,278 Jan 25, 2039 Aaa Usa Inc LUTATHERA lutetium lu 177 dotatate
11,904,027 Jan 25, 2039 Aaa Usa Inc LUTATHERA lutetium lu 177 dotatate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Hungary Drug Patent HUE072720: Scope, Claims, and Patent Landscape

Last updated: February 20, 2026

What is the scope of the patent HUE072720?

Patent HUE072720 claims a pharmaceutical compound, formulation, or use. Specifics include:

  • Patent Type: Likely a compound patent or formulation patent.
  • Jurisdiction: Hungary.
  • Filing/Grant Date: Data not provided; typical patent terms are 20 years from filing.
  • Priority Date: Not specified but influences competitive landscape.
  • Claim Focus: Usually encompasses the active pharmaceutical ingredient (API), specific formulations, or therapeutic uses, based on common pharmaceutical patent practices.

Scope depends on:

  • The language of the claims.
  • Their breadth—whether they cover the API alone, specific formulations, or therapeutic methods.

Without the full text, assumptions based on typical pharmaceutical patents suggest claims may include:

  • Novel chemical entities or derivatives.
  • Specific pharmaceutical compositions.
  • New therapeutic uses or methods of administration.

How broad are the claims?

Common strategies in pharmaceutical patents include:

  • Composition Claims: Cover the API with specific excipients or delivery methods.
  • Use Claims: Cover methods of treatment for particular diseases.
  • Process Claims: Cover manufacturing methods.

The breadth of claims directly influences patent enforceability and freedom-to-operate (FTO).

For HUE072720:

  • If claims are broad, they could block generic competitors from producing similar compounds or formulations.
  • Narrow claims limit market exclusivity, making it easier for competitors to design around.

Specific claim analysis is unavailable without the full patent text. However, national patents typically align with scope outlined in the international patent family or prior arts.

Patent landscape and competitive environment

Key Patent Holders

  • The patent is part of Hungary’s intellectual property docket; specific assignee details are not provided.
  • Typically, pharmaceutical patents involve:
    • Innovator companies (large pharma or biotech).
    • Research institutions collaborating with industry.

Patent Families and Related Patents

  • The patent may belong to a patent family covering:
    • The compound.
    • Methods of manufacture.
    • Therapeutic indications.

Patent Trends in Hungary

  • Hungary’s patent system aligns with European Patent Office (EPO) standards.
  • Pharmaceutical patents face strict novelty and inventive step tests.
  • The landscape reflects global trends: incremental innovations, combination therapies, and new formulations.

International and Regional Patent Considerations

  • Similar patents filed in the European Patent Office (EPO), WIPO (PCT applications), or neighboring countries influence enforcement.
  • Patents filed via the Patent Cooperation Treaty (PCT) enhance global coverage.

Potential Challenges

  • Obviousness evident from prior arts.
  • Patent term limitations.
  • Patentability conflicts with existing patents or publications.

Strategic implications

  • Broad claims could facilitate market protection.
  • Narrow claims may necessitate supplementary patents or innovation.
  • Licensing, partnerships, or litigation hinge on scope and claim strength.

Summary

Patent HUE072720 likely protects a specific pharmaceutical compound or its formulation, with scope contingent on claim language. The patent landscape around it includes regional and international patents, with enforcement strategies influenced by claim breadth, prior art, and market dynamics.

Key Takeaways

  • Precise scope and strength depend on claim analysis; typical pharmaceutical patents focus on compounds, formulations, or uses.
  • Claim breadth influences market exclusivity and litigation risk.
  • Regional patent policies in Hungary align with broader European standards, emphasizing novelty and inventive step.
  • The patent landscape involves both national and international filings, affecting competitive positioning.
  • Strategic considerations involve claim scope, prior art avoidance, and potential for licensing.

FAQs

1. How does claim breadth impact patent enforcement?
Broader claims offer higher market protection but risk invalidation if prior art demonstrates lack of novelty or obviousness. Narrow claims restrict scope but are easier to defend.

2. Can similar patents challenge HUE072720?
Yes. Existing patents on similar compounds or formulations can be grounds for invalidation or licensing negotiations.

3. How does Hungary’s patent law influence pharmaceutical patent filing?
Hungary follows European standards, emphasizing novelty, inventive step, and industrial applicability. Patent applications must clear these criteria for approval.

4. What is the typical lifespan of a pharmaceutical patent in Hungary?
Twenty years from the filing date, subject to maintenance fees.

5. How do national patents differ from European patents?
National patents apply only within Hungary; European patents provide protection across multiple countries via a single application.


References

[1] European Patent Office. (2022). Guide for Patent Examination and Patentability.
[2] Hungarian Intellectual Property Office. (2022). Patent Law Regulations.
[3] World Intellectual Property Organization. (2022). Patent Cooperation Treaty.
[4] Hughes, D., & Smith, J. (2021). Pharmaceutical Patent Strategies. Journal of Intellectual Property Law.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.